Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed.
Three separate studies reported an increase in Guillain-Barré syndrome (GBS) shortly after the roll out of the AstraZeneca vaccine.
GBS is a potentially deadly condition in which a person’s immune system attacks their nerves and gradually paralyses victims from the feet upwards. While most patients recover, it can be life-threatening or permanently debilitating.
